Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia
Pasquale Anthony Della Rosa, Chiara Cerami, Francesca Gallivanone, Annapaola Prestia, Anna Caroli, Isabella Castiglioni, Maria Carla Gilardi, Giovanni B. Frisoni, Karl Friston, John Ashburner, Daniela Perani (2014). A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia. Neuroinformatics, 12(4), pp. 575-593, DOI: 10.1007/s12021-014-9235-4.
Article418 days agoFunctional MRI to monitor disease progression in patients with rare kidney disease
Anna Caroli, Giulia Villa, Erica Daina, Paolo Brambilla, Sara Gamba, Valentina Leone, Camillo Carrara, Paola Rizzo, Marina Noris, Giuseppe Remuzzi, Andrea Remuzzi (2024). Functional MRI to monitor disease progression in patients with rare kidney disease. , DOI: https://doi.org/10.58530/2023/1295.
Article43 days agoDiffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD
Anna Caroli, Giulia Villa, Paolo Brambilla, Matias Trillini, Kanishka Sharma, Sandro Sironi, Giuseppe Remuzzi, Norberto Perico, Andrea Remuzzi (2023). Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD. , 33(9), DOI: https://doi.org/10.1007/s00330-023-09601-4.
Article43 days agoEffects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial
Matias Trillini, Anna Caroli, Norberto Perico, Andrea Remuzzi, Paolo Brambilla, Giulia Villa, Annalisa Perna, Tobia Peracchi, Nadia Rubis, Davide Martinetti, Rosa Caruso, Valentina Fanny Leone, Daniela Cugini, Fabiola Carrara, Giuseppe Remuzzi, Piero Ruggenenti (2023). Effects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial. , 18(2), DOI: https://doi.org/10.2215/cjn.0000000000000049.
Article43 days agoSupplementary Material for: Functional Magnetic Resonance Imaging to Monitor Disease Progression: a prospective study in Patients with Primary Membranoproliferative Glomerulonephritis
Giulia Villa, Erica Daina, Paolo Brambilla, Sara Gamba, Leone V.F., C. Carrara, Paola Rizzo, Marina Noris, Giuseppe Remuzzi, Andrea Remuzzi, Anna CaroliSupplementary Material for: Functional Magnetic Resonance Imaging to Monitor Disease Progression: a prospective study in Patients with Primary Membranoproliferative Glomerulonephritis. , DOI: https://doi.org/10.6084/m9.figshare.24495352.
Dataset43 days ago